Richard Assaf, MD
Dermatology · Westlake, OHNPI 1669421392
Payments from drug & device makers
Across 582 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EPI Health, LLC$5K
- AbbVie$2K
- Pfizer$1K
- Sun Pharmaceutical Industries Inc.$940
- Regeneron Healthcare Solutions, Inc.$839
- Galderma Laboratories, L.p.$812
- plus $6K from 24 others
What the payments were for
- Speaking & faculty fees$3,07619%
- Travel & lodging$1,1297%
- Food & beverage$11,89474%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EPI Health, LLC | 14 | $4,848 |
| AbbVie | 73 | $1,885 |
| Pfizer | 64 | $1,026 |
| Sun Pharmaceutical Industries Inc. | 53 | $940 |
| Regeneron Healthcare Solutions, Inc. | 36 | $839 |
| Galderma Laboratories, L.p. | 55 | $812 |
| Lilly USA, LLC | 31 | $604 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $509 |
| LEO Pharma Inc. | 24 | $474 |
| Dermavant Sciences, Inc. | 33 | $472 |
| E.r. Squibb & Sons, L.L.C. | 22 | $399 |
| Johnson & Johnson | 21 | $393 |
| Sanofi | 18 | $382 |
| Almirall LLC | 18 | $342 |
| UCB, Inc. | 12 | $329 |
| Incyte Corporation | 13 | $275 |
| Boehringer Ingelheim | 7 | $252 |
| Novartis | 14 | $241 |
| Mayne Pharma Commercial LLC | 11 | $234 |
| Dermira, Inc. | 3 | $160 |
| Journey Medical Corporation | 2 | $148 |
| VYNE Pharmaceuticals Inc. | 8 | $145 |
| Organon | 11 | $112 |
| Amgen | 4 | $106 |
| Arcutis Biotherapeutics, Inc. | 4 | $64 |
| Verrica Pharmaceuticals Inc. | 2 | $40 |
| Biofrontera Inc. | 2 | $31 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $23 |
| LNHC, Inc | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,122 in reported general payments places this provider in the 80th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 27 | $3,161 |
| Clobetasol Propionate | 63 | $2,697 |
| Tretinoin | 32 | $1,383 |
| Mometasone Furoate | 58 | $1,059 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 45 | $882 |
| CiclopiroxCiclopirox Olamine | 23 | $421 |
| Ketoconazole | 33 | $389 |
| Doxycycline Monohydrate | 23 | $387 |
| Fluconazole | 25 | $373 |
| Clindamycin Phosphate | 11 | $314 |
| Triamcinolone Acetonide | 55 | $296 |
| Mupirocin | 36 | $216 |
| Nystatin | 14 | $185 |
| ValacyclovirValacyclovir Hcl | 11 | $166 |
| Hydrocortisone | 32 | $148 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westlake
- Michael ReepWestlake$308K
- Paul HazenWestlake$33K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jeffrey TraversDayton$4.7M
- Jennifer NashWesterville$4M
- Jessica KaffenbergerColumbus$3.2M
- Rocco SerraoDayton$3M
- Patrick ShannonBoardman$2M
- George DrewMarion$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.